Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.49 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.49 |
| ▸ | ATM | Q13315 | 1/20 | 0.49 |
| ▸ | TACR1 | P25103 | 1/20 | 0.48 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.46 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.45 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | CCR5 | P51681 | 4/20 | 0.42 |
| ▸ | GPR119 | Q8TDV5 | 2/20 | 0.42 |
| ▸ | CKS1B | P61024 | 1/20 | 0.42 |
| ▸ | SKP1 | P63208 | 1/20 | 0.42 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.42 |
| ▸ | STS | P08842 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7600715 | 0.83 | ALDH1A1 (0.60) | TSHRALOX15ATMTACR1OPRD1 | |
| SCHEMBL8364780 | 0.83 | TSHR (0.50) | TSHRALOX15ATMTACR1OPRD1 | |
| SCHEMBL4630124 | 0.83 | TSHR (0.50) | TSHRALOX15ATMTACR1OPRD1 | |
| SCHEMBL8364745 | 0.81 | TSHR (0.52) | TSHRALOX15ATMTACR1OPRD1 | |
| SCHEMBL6543160 | 0.81 | TSHR (0.57) | TSHRALOX15ATMTACR1OPRD1 | |
| SCHEMBL28872311 | 0.78 | TSHR (0.54) | TSHRALOX15ATMTACR1OPRD1 | |
| SCHEMBL4631302 | 0.78 | ALDH1A1 (0.60) | TSHRALOX15ATMTACR1OPRD1 | |
| SCHEMBL8364603 | 0.76 | EPHX1 (0.57) | TSHRALOX15ATMTACR1OPRD1 | |
| SCHEMBL6423231 | 0.76 | KMT2A (0.51) | TSHRPOLBKDM4EPKMALDH1A1 | |
| SCHEMBL2470236 | 0.75 | HDAC3 (0.54) | TSHRALOX15ATMTACR1OPRD1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6465489-B1 | SUCH AS 1-BENZOYL-3-(3,4-DICHLOROPHENYL)-3-(3-(4-(N',N'-DIMETHYLUREIDO)-4 -PHENYLPIPERIDIN-1-)PROPYL)PIPERIDINE; PSYCHIATRIC AND PSYCHOSOMATIC ILLNESSES, HYPERTENSION, CENTRAL OR PERIPHERAL PATHOLOGY | SANOFI-SYNTHELABO (FR) | 2002-10-15 | — | — | US | disclosed |
| EP-1119552-A1 | UREIDOPIPERIDINE DERIVATIVES AS SELECTIVE HUMAN NK 3? RECEPTOR ANTAGONISTS | SANOFI-SYNTHELABO (FR) | 2001-08-01 | — | — | EP | disclosed |
| WO-2000021931-A1 | UREIDOPIPERIDINE DERIVATIVES AS SELECTIVE HUMAN NK3 RECEPTOR ANTAGONISTS | SANOFI-SYNTHELABO (FR) | 2000-04-20 | — | — | WO | disclosed |
| US-5965580-A | TREATMENT OF SUBSTANCE P- AND NEUROKININ-DEPENDENT DISORDERS | SANOFI (FR) | 1999-10-12 | — | — | US | disclosed |
| US-5939411-A | PIPERIDINE DERIVATIVES SUBSTITUTED AT POSITION 4 WITH NEW FUNCTIONS OTHER THAN THOSE DESCRIBED PREVIOUSLY HAVE A HIGH AFFINITY FOR NEUROKININ RECEPTORS AND ARE USEFUL FOR TREATMENT OF SUBSTANCE P AND NEUROKININ DEPENDENT PATHOLOGIES | SANOFI (FR) | 1999-08-17 | — | — | US | disclosed |
| US-5830906-A | Piperidine derivatives, process for obtaining them and pharmaceutical compositions containing them | SANOFI (FR) | 1998-11-03 | — | — | US | disclosed |